Life-Prolonging Treatments for Advanced Prostate Cancer - Maha Hussain
January 30, 2019
Maha Hussain joins Alicia Morgans and reflects on the journey she has traveled from 1983 when prostate cancer was viewed as a disease exclusive to older men, where there were no real biomarkers and a lack of understanding for the spectrum of the disease. Maha delivers one of the pivotal talks at the PCF 25th Annual retreat and here we gain her perspective on the evolving landscape of life-prolonging treatments for advanced disease in men with prostate cancer.
Biographies:
Maha Hussain, MD, FACP, FASCO, is the Genevieve Teuton Professor of Medicine in the Division of Hematology Oncology, Department of Medicine, and the Deputy Director at the Robert H. Lurie Comprehensive Cancer Center of the Northwestern University Feinberg School of Medicine.
Alicia Morgans, MD, MPH, Associate Professor of Medicine in the Division of Hematology/Oncology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Biographies:
Maha Hussain, MD, FACP, FASCO, is the Genevieve Teuton Professor of Medicine in the Division of Hematology Oncology, Department of Medicine, and the Deputy Director at the Robert H. Lurie Comprehensive Cancer Center of the Northwestern University Feinberg School of Medicine.
Alicia Morgans, MD, MPH, Associate Professor of Medicine in the Division of Hematology/Oncology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.